EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Effect of 4-Month Treatment with Glycocalyx Dietary Supplement on Endothelial Glycocalyx Integrity and Vascular Function in Patients with Psoriasis

Ignatios Ikonomidis iD, Eleni Katsanaki iD, John Thymis iD, George Pavlidis iD, Kyriaki Lampadaki, Konstantinos Katogiannis iD, Aristeidis Vaiopoulos iD, Vicky Lazarou, Gavriella Kostelli iD, Eleni Michalopoulou, Sotirios Pililis iD, Dimitrios Vlachomitros und 5 weitere

Nutrients · 05.08.2024 · 16 (15) · 2572

DOI: 10.3390/nu16152572 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 05.08.2024. Verfasst von Ignatios Ikonomidis und 16 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Cardiology Department, Attikon University Hospital, National & Kapodistrian University of Athens, 12461 Athens, Greece. Hauptthemen laut MEDLINE: Glycocalyx, Psoriasis, Dietary Supplements, Vascular Stiffness. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis predisposes to cardiovascular dysfunction. We investigated whether glycocalyx dietary supplement (GDS), which contains glycosaminoglycans and fucoidan, improves endothelial glycocalyx and arterial stiffness in psoriatic patients. Fifty participants with psoriasis under biological agents were randomly assigned to GDS (n = 25) or placebo (n = 25) for 4 months. We measured at baseline and at follow-up: (a) perfused boundary region (PBR) of the sublingual microvessels (range 4 to 25 μm), a marker of endothelium glycocalyx integrity; (b) carotid–femoral pulse wave velocity (PWV-Complior SP-ALAM) and augmentation index (AIx), markers of arterial stiffness and (c) psoriasis area and severity index (PASI) score. Both groups displayed a similar decrease in PASI at four months (p < 0.05), and no significant differences were found between groups (p > 0.05). Compared to the placebo, participants in the GDS showed a greater percentage reduction in PBR4–25 μm (−9.95% vs. −0.87%), PBR 4–9 μm (−6.50% vs. −0.82%), PBR10–19 μm (−5.12% vs. −1.60%), PBR 20–25 μm (−14.9% vs. −0.31%), PWV (−15.27% vs. −4.04%) and AIx (−35.57% vs. −21.85%) (p < 0.05). In the GDS group, the percentage reduction in PBR 4–25 μm was associated with the corresponding decrease in PWV (r = 0.411, p = 0.015) and AΙx (r = 0.481, p = 0.010) at follow-up. Four-month treatment with GDS improves glycocalyx integrity and arterial stiffness in patients with psoriasis. Clinical trial Identifier: NCT05184699.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycocalyxPsoriasisDietary SupplementsVascular StiffnessEndothelium, VascularHumansMaleFemaleAdultMiddle AgedDouble-Blind MethodTreatment Outcome

Stichwörter der Autor:innen

arterial stiffnessaugmentation indexfucoidanglycocalyxglycocalyx dietary supplementpsoriasispulse wave velocity

Autor:innen und Institutionen

  • 2nd Cardiology Department, Attikon University Hospital, National & Kapodistrian University of Athens, 12461 Athens, Greece.
  • 2nd Department of Dermatology and Venereology, Attikon University Hospital, Medical School, National & Kapodistrian University of Athens, 12461 Athens, Greece.
  • Research Unit and Diabetes Center, 2nd Department of Internal Medicine, Attikon University Hospital, National & Kapodistrian University of Athens, 12461 Athens, Greece.
  • GlycoCalyx Research Institute, Alpine, UT 84004, USA.

ORCID-Profile: Ignatios Ikonomidis, Eleni Katsanaki, John Thymis, George Pavlidis, Konstantinos Katogiannis, Aristeidis Vaiopoulos, Gavriella Kostelli, Sotirios Pililis, Konstantinos Theodoropoulos

Zitieren

APA

Ikonomidis, I., Katsanaki, E., Thymis, J., Pavlidis, G., Lampadaki, K., Katogiannis, K., Vaiopoulos, A., Lazarou, V., Kostelli, G., Michalopoulou, E., Pililis, S., Vlachomitros, D., Theodoropoulos, K., Vink, H., Long, R., Papadavid, E., & Lambadiari, V. (2024). The Effect of 4-Month Treatment with Glycocalyx Dietary Supplement on Endothelial Glycocalyx Integrity and Vascular Function in Patients with Psoriasis. Nutrients, 16(15), 2572. https://doi.org/10.3390/nu16152572

Vancouver

Ikonomidis I, Katsanaki E, Thymis J, Pavlidis G, Lampadaki K, Katogiannis K, et al. The Effect of 4-Month Treatment with Glycocalyx Dietary Supplement on Endothelial Glycocalyx Integrity and Vascular Function in Patients with Psoriasis. Nutrients. 2024;16(15):2572. doi:10.3390/nu16152572

BibTeX
@article{Ikonomidis2024,
  author = {Ikonomidis, Ignatios and Katsanaki, Eleni and Thymis, John and Pavlidis, George and Lampadaki, Kyriaki and Katogiannis, Konstantinos and Vaiopoulos, Aristeidis and Lazarou, Vicky and Kostelli, Gavriella and Michalopoulou, Eleni and Pililis, Sotirios and Vlachomitros, Dimitrios and Theodoropoulos, Konstantinos and Vink, Hans and Long, Robert and Papadavid, Evangelia and Lambadiari, Vaia},
  title = {The Effect of 4-Month Treatment with Glycocalyx Dietary Supplement on Endothelial Glycocalyx Integrity and Vascular Function in Patients with Psoriasis},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {15},
  pages = {2572},
  doi = {10.3390/nu16152572}
}
Kostenlos starten →